C.T. Fitzpatrick - Vulcan Value Partners,
Period:    Q1 2026
Portfolio date:    31 Mar 2026
No. of stocks:    33
Portfolio value:    $3,772,296,111
Holdings Activity Buys Sells    History
Holding/activity history for  Teva Pharmaceutical Industries Ltd. (TEVA)
Period Shares % of Portfolio Activity % Change to Portfolio Reported Price Value Filing
2011   Q3 0 0.00 Sell 100.00% 5.10 SEC
2011   Q2 202,942 5.10 Add 63.33% 1.98 $48.22 $9,786,000 SEC
2011   Q1 124,250 4.57 Add 25.86% 0.94 $50.17 $6,234,000 SEC
2010   Q4 98,718 4.99 $52.13 $5,146,000 SEC